Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease
Status:
Completed
Trial end date:
2019-10-10
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effectiveness of tacrolimus (prograf) versus
prednisolone for the treatment of nephrotic syndrome secondary to minimal change disease.